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Abstract Glycogenin, the self-glucosylating primer for glycogen synthesis, is expressed in wild-type E. coli as a recombinant protein in an already 
partly glucosylated form, owing to the presence of its substrate, UDP-glucose. By using an E. coli mutant strain lacking in UDP-glucose pyro- 
phosphorylase activity, we have succeeded in expressing carbohydrate-free glycogenin (apo-glycogenin) in good yield. When provided with UDPxy- 
lose, it autocatalytically adds 1 xylose residue. With UDP-glucose, an average of 8 glucose residues are added. However, release of the self-synthesized 
maltosaccharide chains with isoamylase reveals them to be a mixture. Chains as long as 11 glucose residues (maltoundecaose) are present. The ability 
of recombinant apo-glycogenin to self-glucosylate is further proof that a separate nzyme is not needed for the addition of the first glucose residue 
to Tyr-194 of the protein. 
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1. Introduction 
Glycogenin is the self-glucosylating protein that primes gly- 
cogen synthesis and remains as a covalently bound part of the 
glycogen molecule (for reviews see [ 1,2]). It does not occur in 
muscle in the free state and is obtained, enzymically active, by 
degradation of the glycogen. The product still carries tyrosine- 
bound maltosaccharide, representing the originating chain 
(C-chain) of the glycogen molecule. When the recombinant 
enzyme is expressed in E. coli, the enzyme also carries a malto- 
saccharide chain [3,4]. This is because E. coli contains the glyco- 
genin substrate, UDP-glucose, synthesized by UDP-glucose py- 
rophosphorylase. The autocatalysis includes the ability to glu- 
cosylate Tyr-194, as well as to add the next several 1,4-linked 
a-glucose units that constitute the maltosaccharide primer 
chain for further elongation by glycogen synthase [S]. There- 
fore, once expressed in the E. coli cell, the glycogenin proceeds 
to glucosylate itself. 
In order to study the properties of glycogenin further, includ- 
ing X-ray crystallographic analysis, there is a need to obtain the 
enzyme in a carbohydrate-free state (apo-glycogenin). Until 
now, the only available procedure made use of the ability of the 
glycogen debranching enzyme, isoamylase, to split the linkage 
between the glycogen C-chain and Tyr-194 [5,6]. This proce- 
dure is unsatisfactory because the wide difference in pH optima 
between isoamylase and glycogenin (over 3 pH units) results in 
the partial inactivation of the latter. Also, isoamylase will only 
remove the C-chain if it is at least 3 glucose units in length. 
We have overcome this problem by employing an expression 
system for rabbit muscle glycogenin in an E. coli strain that 
lacks UDP-glucose pyrophosphorylase activity, and have stud- 
ied some of the properties of the carbohydrate-free product, 
which is synthesized in good yield in a fully active form. 
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2. Materials aud methods 
2. I. Materials 
E. coli CGSC 4954 was obtained from the E. coli Genetic Stock 
Center, Department of Biology, Yale University, PO Box 6666, New 
Haven, CT 06511-8155, USA. It is a galactose-minus strain lacking 
UDP-glucose pyrophosphorylase activity, the assignment of its lesion 
being galU106. Isoamylase was a gift from Hayashibara Biochemical 
Laboratories, Hiroshima, Japan. Glucose oxidase, peroxidase and crys- 
talline pancreatic trypstin (180 ,@mg) were obtained from Boehringer- 
Mannheim. Radioactive UDP-glucose and UDP-xylose were pur- 
chased from American Radiolabeled Chemicals. Sep-Pak C,, cartridges 
were from Millipore. Bio-Rex RG 501-X8 resin was a Bio-Rad product. 
Costar microtitration plates were used. Except as noted, all other rea- 
gents came from Sigma. 
2.2. Preparation of E. coli CGSC 4954 for expression of glycogenin 
cloned into a PET vector 
The cloning of rabbit muscle glycogenin cDNA and its subcloning 
into a PET-lld expression vector are reported elsewhere [4,5]. A 
lysogenization kit (Novagen) for site-specific integration of a T7 RNA 
polymerase gene-containing prophage, ;1DE3, into the E. coli CGSC 
4954 chromosome was used to generate a lysogenized host capable of 
expressing target genes cloned in PET vectors under the control of the 
T7 promoter. Lysogenization and verification of CGSC 49541DE3 
lysogens were done according to the manufacturer’s guidelines. The 
lysogenic bacterial clone chosen for expression was designated CGSC 
4954- 1. 
2.3. Expression and purification of apo-glycogenin 
The recombinant PET-lld vector containing the wild-type glyco- 
genin cDNA, PET-R [4], was transformed into E. coli CGSC 4954-l. 
Cultures of transformed bacteria were started-up by inoculation at high 
dilution of growth medium (12 g of tryptone, 24 g of yeast, 10 g of NaCl, 
0.25 g of Tris-base and 4 ml of glycerol per 1 of water) supplemented 
with ampicillin at 200 yg/ml and grown at 27°C for 12 h. The temper- 
ature was then raised to 37°C. When the culture reached an optical 
density of 0.6 (1 cm), induction was started by addition of isopropyl 
p-o-thiogalactopyranoside to 1 mM. Fermentation was allowed to pro- 
ceed for 3 h before the cells were harvested by centrifugation (4000 rpm 
for 15 min). The same two-step purification procedure reported for the 
wild-type, Phe-194 and Thr-194 mutant forms of glycogenin was used 
to obtain homogeneous protein [5]. 
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2.4. Immunoblotting 
The procedure used by Lomako et al. [7] was followed, using a 
polyclonal antibody generated with native rabbit-muscle glycogenin as 
antigen. 
2.5. Self+ucosylation reactions 
The self-glucbsylation reaction mixtures (100 ~1 each) contained 50 
mM Tris-HCl. DH 7.4. 5 mM Mr?‘. and 20 uM UDPI“‘Clalucose or 
UDP[‘4C]xylose. When the glucose donor was used, the reaction was 
incubated at room temperature for 2 h before TCA precipitation and 
counting (see [q/1). Reactions with the xylose donor were incubated for 
2 h, 4 h and overnight at room temperature before TCA precipitation 
and counting. The results reported for xylose incorporation correspond 
to overnight incubations. Initial reaction rates were obtained with 20 
PM radiolabeled UDP-glucose after 5 min. 
2.6. Glucose determination 
A highly sensitive glucose oxidase assay [S] capable of detecting 
amounts of glucose down to 20 ng was used to determine whether 
glycogenin expressed in the UDP-glucose pyrophosphorylase-deficient 
E. coli strain was glucosylated. If the protein contained a minimum of 
one glucose unit per molecule, 1OOpg would yield 0.5 pg of glucose, an 
amount well within the range of the assay, and detectable after acid 
hydrolysis (Table 1). For this reason, 100 pg of purified protein, f 0.5 
pg of added glucose, along with 1OOpg of Phe-194 glycogenin mutant 
(negative control) were subjected to acid hydrolysis in a PICO-TAG 
Work Station (Waters) and subsequent glucose determination. Galac- 
tose (50 pg) was added to each protein sample to minimize the loss of 
glucose in hot acid. After addition of the galactose, the solutions were 
dried in Kimax hydrolysis tubes under speed vacuum in a concentrator 
(Savant), and 2 M trifluoroacetic acid (200 ~1) was pippeted into the 
bottom of a reaction vial where the tubes were placed. In order partially 
to evaporate the acid, the capped reaction vial was installed into the 
PICO-TAG Work Station and a vacuum (l-2 Torr) was applied. The 
vacuum valve was then closed and the vial placed in an oven at 100°C 
for 4 h. The residues in the hydrolysis tubes were vacuum dried, resus- 
pended in water (20 ~1) and transferred to microtitration plates for the 
glucose determination assay. Water was pippeted into a separate row 
of wells to serve as a reagent blank. Stock solutions containing 0.5 pg 
and 1 pg glucose/20 ~1 were used as standards. The glucose oxidase 
reagent (100 ~1) consisting of 0.1 M citrate-sodium citrate buffer, pH 
6.0, containing 15 U of glucose oxidase/ml, 2.5 U of peroxidase/ml, 
0.05% bovine serum albumin and 0.07% 3,3’, 5 5’-tetramethylbenzidine, 
was added to each well, and the plate stored at 37°C for 10 min. After 
adding 100 ~1 of 0.9 M H,SOI to each well, the color produced was 
analyzed at 450 nm in a microplate reader (SLT-Labinstruments). 
2.7. Debranching of fully [“C]glucosylated apo-glycogenin a d 
analysis of the released maltosaccharide chains 
Approximately 90 pmol of purified protein were allowed to self- 
radioglucosylate for 2 h at room temperature. The labeled protein was 
then separated from the other constituents of the reaction mixture in 
an 8 ml Sephadex G25 column, in 25 mM ammonium bicarbonate, pH 
8.0, 2 mM CHAPS. The label emerged in two 400 ~1 fractions which 
were lyophilyzed, resuspended in water (80 ~1) and subjected to trypsi- 
nolysis with enzyme (0.165 pg) in 0.5 M ammonium bicarbonate pH 
8.5 (20 ~1) at 37°C for 4 h, when 0.1 M phenylmethylsulfonyl fluoride 
in propane-2-01 (  ~1) was added. The 100 ,ul digest was then taken to 
200 pl with the addition of sodium acetate buffer, pH 4.5, to a final 
acetate concentration of 0.1 M, plus 180 U of isoamylase. After an 
overnight incubation at room temperature, the released ‘QZ-labeled 
oligosaccharides were desalted and purified by passage through a 
mixed-bed resin column (0.5 ml, Bio-Rex RG501-X8) connected to a 
Sep-Pak C,, reverse-phase cartridge prewetted with acetonitrile. Elu- 
tion was accomplished with 5 ml of water in 0.5 ml fractions in which 
the 14C-lebeled oligosaccharides were detected by scintillation counting 
and combined. After lyophylization, the radiolabeled material was dis- 
solved in 30 ~1 of water, of which 10 ~1 were chromatographed on 
Whatman 3MM paper in butanol : pyridine :water (6 : 4 : 3, by vol.) A 
mixture of glucose, maltose, maltotriose, maltotetraose, maltopentaose 
and maltoheptaose was used for reference. After eight solvent ascents, 
the chomatogram was dried and exposed to Kodak X-OMAT AR film 
for 1 week. Standards were revealed by alkaline silver nitrate [9] (see 
Fig. 3). 
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Fig. 1. SDS-PAGE analysis of glycogenins expressed in BL21/DE3 and 
CGSC 4954 E. coli hosts, with proteins revealed by staining with 
Coomassie blue. Lane 1, wild-type glycogenin expressed in the BL21/ 
DE3 UDP-glucose-synthesizing host. Lane 2, Phe-194 mutant glyco- 
genin expressed in the same host. Lane 3, wild-type glycogenin ex- 
pressed in the CGSC 4954, UDP-glucose-deficient host. 
3. Results and discussion 
3.1. Preparation and properties of apo-glycogenin 
The strain of E. coli used as the host for the expression of 
glycogenin is one known to be lacking in UDP-glucose pyro- 
phosphorylase activity [lo]. This does not affect glycogen syn- 
thesis because the nucleoside diphosphate precursor for E. coli 
glycogen is ADP-glucose [l 11. Nor is glycogenin known to be 
the primer for E. coli glycogen synthesis. 
We used the same expression system as for the synthesis of 
the recombinant wild-type, Phe-194 and Thr-194 mutant glyco- 
genins [4,5]. There the level of expression was excellent and a 
two-step, 2.5-fold purification process is sufficient to obtain 
homogeneous products in overall yields from 25% (Phe-194) to 
49% (wild-type). The same procedure works equally well for the 
recombinant protein from the E. coli CGSC 4954-l strain. We 
did not quantitate the recovery of apo-glycogenin (the yield of 
pure protein is about 4 mg/lOO ml of medium) but the Coomas- 
sie blue stain of the lysate after SDS-PAGE (Fig. 1, lane 3) 
reveals that a protein band in the expected position for carbo- 
hydrate-free glycogenin was the most prominent component, 
comparable in amount to the wild-type enzyme [4,5]. We can 
refer to the expected position because, for comparison, the 
wild-type (Fig. 1, lane 1) and Phe-194 mutant (Fig. 1, lane 2) 
recombinant proteins were also subjected to SDS-PAGE. The 
wild-type enzyme, already carrying carbohydrate which would 
increase its mass by approx. 1 kDa, is seen to migrate notice- 
ably slower than the presumed carbohydrate-free Phe-194 pro- 
tein, which cannot glucosylate itself [4,5,12]. The major protein 
band in the E. coli CGSC 4954-l lysate migrates with the 
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Fig. 2. Immunoblotting of recombinant glycogenins after SDS-PAGE. 
1, wild-type; 2, 7 apo-glycogenin b fore self-glucosylation; 3, Phe-194 
mutant protein; 4, Thr-194 mutant protein; 5, wild-type; 6, apo-glyco- 
genin after self-glucosylation. The numbers at the left correspond to the 
positions occupied by standards with masses of 45 and 31 kDa. 
Phe-194 mutant protein (Fig. 1, lanes 2,3). When purified to 
homogeneity and examined by immunoblotting with the same 
reference proteins, the differences in IV, were maintained (Fig. 
2). The wild-type enzyme (Fig. 2, lanes 1,5) is seen to have a 
higher M, than apo-glycogenin (Fig. 2, lane 2) or the Phe-194 
(Fig. 2, lane 3) and Thr-194 (Fig. 2, lane 4) mutant proteins 
[4,5]. Also the wild-type band is more diffuse because it is only 
incompletely glucosylated (see below) and there is heterogene- 
ity between the maltosaccharide chains. This is noted also in 
the lower panel where the apo-glycogenin is seen to increase in 
M, after self-glucosylation (Fig. 2, lanes 6 vs. 7) and the more 
fully glucosylated enzyme gives a sharper band than does the 
incompletely glucosylated wild-type enzyme. 
We devised a microchemical analytical procedure to carry 
out what we believe to be the first quantitative carbohydrate 
analysis of enzymically active glycogenin. This is based on a 
glucose oxidase assay capable of the accurate determination of 
submicrogram amounts of glucose [8]. Hydrolysis of the protein 
was carried out with 2 M trifluoroacetic acid vapor at 100°C 
for 4 h, followed by enzymic determination of any glucose set 
free. Conditions were established for accurate assessment by 
hydrolysing bovine serum albumin, maltopentaose and glucose 
in test mixtures, with galactose added to all samples to diminish 
the destruction of glucose by acid (which was compensated for 
by putting glucose standards through the same procedure). The 
hydrolysis conditions were judged sufficient to hydrolyse 
bound glucose by checking that they caused complete hydroly- 
sis of maltopentaose. 
Trial experiments revealed that the same amount of glucose 
hydrolyzed in presence of different proteins gave rise to differ- 
ent absorbancies in the glucose oxidase assay. We decided to 
use as the reference the Phe-194 mutant protein corresponding 
to rabbit-muscle glycogenin [4,5]. It cannot glucosylate itself 
and carbohydrate is not known to be linked anywhere else in 
the protein. In Table 1 we show the actual A,,, nm in the ELISA 
reader, corresponding to 100 pg of Phe-194 enzyme vs. 100 pug 
of apo-glycogenin. (The absorbances, relative to water, were 
negative.) The slight difference in absorbance between the two 
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protein samples corresponded to a glucose content in the apo- 
glycogenin of 0.06 molecular proportions. Clearly, within the 
limits of experimental error, and assuming that the Phe-194 
mutant protein was carbohydrate-free, the apo-glycogenin was 
also carbohydrate-free. Therefore we now have the capability, 
for the first time, to synthesize carbohydrate-free glycogenin in 
quantity. 
The homogeneous, carbohydrate-free glycogenin underwent 
self-glucosylation in presence of UDP-glucose and Mn*‘. This 
was a direct demonstration that the addition of the first glucose 
residue, to Tyr-194, is autocatalytic, presumably by the same 
active center that adds a further seven glucose-to-glucose r si- 
dues in a-1,Clinkage (cf. [5]). It is because the chemistry of the 
first glucosidic bond to glycogenin is different from the others 
that there has been hesitancy in assuming that its formation 
would also be autocatalytic, but the probability of this being 
the case was heightened when we found that isoamylase, which 
hydrolyses the interglucosidic branch points of glycogen, also 
hydrolyses the glycogen-tyrosine bond [6]. It was with the use 
of isoamylase that we recently generated carbohydrate-free gly- 
cogenin and demonstrated its autocatalytic apability of reglu- 
cosylating itself [5]. But, as noted above, this is not a satisfac- 
tory method to obtain a fully active, homogeneous carbohy- 
drate-free product. 
3.2. Stoichiometry of self-glycosylation by apo-glycogenin 
The apo-glycogenin readily underwent self-glucosylation and 
incorporated 7.67 f 0.098 (3 measurements) molecular propor- 
tions of glucose. This is close to the expected 8, corresponding 
to malto-octaose, which we earlier identified as the longest 
saccharide released by mild acid hydrolysis of native muscle 
glycogenin [6,13]. With the same enzyme preparation, we had 
also shown that UDP-xylose, an alternative substrate [14,15], 
can be added only once, that is, neither UDP-glucose nor UDP- 
xylose can be used to donate to a maltosaccharide chain already 
capped by xylose [16]. Apo-glycogenin proceeded to add 
0.95 + 0.006 molecular proportions of xylose (3 observations). 
This was, of course, the exactly predictable result but could not 
have been relied on in advance because the previous observa- 
tions of xylose addition had been with glycogenin already car- 
rying maltosaccharide chains. Here we were observing the addi- 
tion of xylose, not to glucose, but to Tyr-194. 
Another aspect of the ability to glucosylate Tyr-194 directly 
Table 1 
Analysis of recombinant glycogenins for glucose content 
1. Apo-glycogenin (100 pg) 
2. Apo-glycogenin (100 pg) + 
free glucose (0.5 pg) 
A absorbance at 450 nm 
-0.115 ? 0.027 (4) 
0.103 + 0.005 (2) 
3. Phe-194 mutant protein (100 pg) -0.128 f 0.017 (4) 
4. Free glucose (0.5 pg) alone 0.326 f 0.012 (2) 
Apo-glycogenin (+ added glucose) and the Phe-194 mutant glycogenin 
were analyzed for their possible content of bound glucose, released by 
acid hydrolysis. Figures in parentheses are the numbers of measure- 
ments. The glucose determination method [8] employed a mixture of 
glucose oxidase and peroxidase, with 3,3’, 5,5’-tetramenthylbenzidine 
as chromophore (see section 2.6). Samples 1-3 were subjected to acid 
hydrolysis. Sample 4 was an untreated glucose standard. Relative to 
water, the protein samples (nos. 1,3) gave negative readings. The ab- 
sorbance difference between samples 2 and 1 (0.218), corresponding to 
the inclusion of 0.5 pg of glucose in sample 2, v. 0.326 for the glucose 
standard, reflects the loss of glucose caused by the hot acid treatment. 
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Fig. 3. Radioautograph of maltosaccharides released from apo-glyco- 
genin after self-glucosylation with UDP[‘%]glucose, followed by trypsi- 
nolysis, hydrolysis with isoamylase, and separation by ascending paper 
chromatography. Details are in section 2. Glucose (G) and maltosac- 
charide (M2 = maltose, etc.) standards ( ilver nitrate strain) re on the 
right(S) and isoamylase-treated glucosylated apo-glycogenin on the left 
(GAP). 
was that of determining the rate of addition of the first glucose 
residue. This might occur at a rate quite different from that of 
subsequent glucoses. We made the comparison between already 
glucosylated wild-type recombinant glycogenin and apo-glyco- 
genin and observed that the latter self-glucosylated at a rate of 
0.45 mol of glucose/mol of enzyme/min. The rate for the already 
partly glucosylated wild-type enzyme was 0.17 mol/mol/min 
and it took up, in total, 3.6 mol of glucose/mole of enzyme vs. 
7.7 for apo-glycogenin. Therefore the rate of addition of the 
first glucose residue to glycogenin is not limiting to the overall 
rate of glucosylation. 
3.3. Upper limit of length of the maltosaccharide chain of 
glycogenin 
Taken together, the self-addition of approximately eight 
glucose residues or one xylose residue to homogeneous apo- 
glycogenin further confirms that the addition of the first sugar 
residue to Tyr-194 does not require the action of a separate 
enzyme, a possibility that was once considered [2]. The glucose- 
to-tyrosine transferring activity is evidently contained within 
glycogenin and is most likely the same active center that carries 
out glucose-to-glucose transfer. 
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We proceeded to examine the lengths of the maltosaccharide 
chains of fully “C-glucosylated apo-glycogenin, using isoamy- 
lase to split the bonds to tyrosine [5,6]. The products were 
separated by paper chromatography and a radioautograph pre- 
pared (Fig. 3). It becomes clear from this experiment, what had 
previously been suspected when native glycogenin was similarly 
treated, that 8 glucose residues is not a fixed and upper limit 
to the self-growth of the primer chain. In isoamylase-treated 
native glycogenin we had seen maltosaccharides with 4-10 glu- 
cose residues, 7 and 8 predominating [6]. Some maltopentaose 
was also present. In the present case we see 7-l 1 glucose resi- 
dues as the major products, in about equal amounts. We should 
note that the qualitative comparison of spot intensities as a 
means of judging relative amounts will be more valid in this 
experiment because, since we were using apo-glycogenin, all 
glucose residues were radiolabelled. Previously, using already 
glucosylated native glycogenin, the amount of i4C introduced 
into the chains was dependent on their initial and, probably, 
variable length. 
We may conclude that glycogenin has the capability of 
lengthening its maltosaccharide chain to 11 (or even higher) 
rather than the 8 glucose residues previously supposed [6,12], 
but that elongation sometimes does not proceed to completion. 
Connected with this would be whether the chain elongation is 
multichain or single chain, a possibility beyond the scope of this 
report. A further relevant factor is whether the self-glucosyla- 
tion is intra- or inter-molecular. Other workers have concluded 
that the reaction is intramolecular, based on first-order kinetics 
when the enzyme concentration is varied [11,17]; but Cohen et 
al. [ 181 reported the muscle enzyme to be a dimer, which renders 
questionable the evidence from kinetics. We have also reported 
that glycogenin is oligomeric [7] and, since glycogenin can 
transglucosylate other acceptor substrates, have suggested that 
the oligomerization may have a purpose, that is, to facilitate 
intermolecular transglucosylation [19]. More recently, we have 
demonstrated that the supposed first-order kinetics break down 
at high dilutions of glycogenin [4]. The rate of decay with 
dilution is suggestive of the dissociation of an interactive com- 
plex. What the variability of maltosaccharide chain length in 
Fig. 3 may represent is the result of association-dissociation of 
glycogenin monomers. Dissociation when, say, the chain had 
reached 8 glucose units would release monomeric glycogenin 
which might well have difficulty in re-uniting with another 
monomer, for further glycosylation. 
Another consideration is the presence, after isoamylase treat- 
ment, of minor amounts of smaller oligosaccharides, even a 
trace of glucose (Fig. 3). Isoamylase does not release glucose 
or maltose, at least when in 1,6-glucosidic linkage. Were these 
minor products the result of an amylase contaminant? The 
isoamylase preparation was amylase-free [6]. The apo-glyco- 
genin, although purified, might be accompanied by a trace of 
hydrolase from the host E. coli. Another possibility is related 
to our report that glycogenin hydrolyses UDP-glucose to glu- 
cose at a rate significant compared with that at which it self- 
glucosylates [4]. It might hydrolyse its own primer chain. Yet 
another possibility is that the pancreatic trypsin used to hy- 
drolyse the glycogenin before isoamylase treatment was con- 
taminated with a-amylase. (The trypsin treatment is necessary 
in order to facilitate isoamylase action [6].) Whatever the reason 
for the traces of glucose and small saccharides, the main conclu- 
sions still stand. 
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We have noted that when recombinant wild-type or apo- 
glycogenin is allowed to self-glucosylate with UDP[‘4C]glucose, 
the reaction does not reach a plateau. Instead the amount of 
protein-bound 14C begins slowly to decrease, suggesting hydrol- 
ysis of the maltosaccharide chain (results not shown). In the 
presence of excess UDP-glucose this would not be expected 
because the enzyme should reglucosylate itself, but, eventually, 
the concomitant hydrolysis of the glucose donor substrate will 
defeat the ability of the enzyme to reglucosylate itself. 
Aspects such as this, and the reason for the range of sac- 
charides seen after isoamylase action, must wait on attempts to 
learn whether the glycosidase and protease activities are inher- 
ent within the recombinant enzymes or are the results of con- 
taminants. 
In conclusion, recombinant apo-glycogenin can be expressed 
in good yield in E. coli in a readily purifiable, fully active 
condition. The means are now open, which we are pursuing, to 
crystallize and study the three-dimensional structure of the 
apo-enzyme, as well as to determine the locations of the impor- 
tant functional sites. A means of doing this has been presented 
by the so-far unpublished observation that partial trypsinolysis 
of glycogenin gives rise to still-active degradation products that 
self-glucosylate but which have a mass only half that of the 
native enzyme. Truncated proteins will be expressed when 
structural information from the tryptic fragments is to hand. 
Acknowledgements: We thank Drs. D.L. Hendrix and A.C. Demnitz- 
King for making available the information on the glucose oxidase assay 
[8]. The work was supported by grants from the National Institutes of 
Health, DK 37500 (to W.J.W.) and AI 22835 (to J.P.). 
M.D. Alonso et al. IFEBS Letters 352 (1994) 222-226 
References 
111 Whelan. W.J. (1986) BioEssavs 5. 136140. 
[41 
[51 
Fl 
171 
PI 
PI 
1101 
PII 
WI 
[I31 
1141 
iI51 
[161 
P71 
iI81 
u91 
Smythe; C. and Cohen, P. (1991)‘Eur. J Biochem. 200, 6255631. 
Kay, M.J., Kirkman, B.R., Lomako, J., Rodriguez, I.R., 
Tandecarz, J.S., Fliesler, S.J. and Whelan, W.J. (1987) Fed. Proc. 
46, 2151. 
Alonso, M.D., Lomako, J., Lomako, W.M. and Whelan, W.J., 
submitted for publication in J. Biol. Chem. 
Alonso, M., Lomako, J., Lomako, W.M. and Whelan, W.J. (1994) 
FEBS Lett. 342, 3842. 
Lomako, J., Lomako, W.M. and Whelan, W.J. (1992) Carbohyd. 
Res. 227, 331-338. 
Lomako, J., Lomako, W.M. and Whelan, W.J. (1988) FASEB J. 
2, 3097-3103. 
Demnitz-King, AC. (1993) Ph.D. Thesis, Wye College, University 
of London, UK. 
Trevelyan, W.E., Proctor, A.P. and Harrison, J.S. (1950) Nature 
166, 444445. 
Shapiro, J.A. (1966) J.Bacteriol. 92, 518-520. 
Greenberg, E. and Preiss, J. (1964) J. Biol. Chem. 239,43144315. 
Cao, Y., Mahrenholz, A.M., DePaoli-Roach, A.A. and Roach, 
P.J. (1993) J. Biol. Chem. 268, 14687-14693. 
Lomako, J., Lomako, W.M. and Whelan, W.J. (1990) Biochem. 
Int. 21, 251-260. 
Meezan, E., Ananth, S., Manzella, S., Campbell, P., Siegal, S., 
Dillion, D.J. and Roden, L. (1994) J. Biol. Chem. 269, 11503- 
11508. 
Roden, L., Ananth, S., Campbell, P., Manzella, S. and Meezan, 
E. (1994) J. Biol. Chem. 269, 11509-11513. 
Lomako, J., Lomako, W.M., and Whelan, W.J. (1990) BioFactors 
2, 251-254. 
Pitcher, J., Smythe, C. and Cohen, P. (1988) Eur. J. Biochem. 176, 
391-395. 
Smythe, C., Watt, P. and Cohen, P. (1990) Eur. J. Biochem. 189, 
199-204. 
Lomako, J., Lomako, W.M. and Whelan, W.J. (1990) FEBS Lett. 
264. 13-16. 
